Feed SNN
SN

Smith & Nephew

SNN · NYSE

$26.43 -0.58% (-$0.16)
1M -8.49%
Market Cap $11.2B
P/E Ratio 17.81x
Div. Yield 2.99%
ROE 11.78%

Bulios Fair Price

$26.9

1.8% upside

Trenutna cena

$26.43

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price se delnica SNN trenutno trguje blizu svoje poštene vrednosti. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Strong
8/9
Valuation
85 /100
Cheap
P/E 17.81x
PEG 0.34x
EV/EBITDA 8.82x
Growth
75 /100
Growing
EPS growth 42.28%
Book val. growth 0.19%
Rev. growth 5.81%
Profitability
79 /100
Strong
Gross margin 68.01%
FCF margin 13.82%
Net margin 10.14%
Quality
52 /100
Average
ROIC 8.95%
Asset turnover 0.59x
ROE 11.78%
Debt
74 /100
Low
Debt/Equity 0.63x
Net debt/EBITDA 1.75x
Current ratio 2.57x
Stability
70 /100
Stable
Beta 0.69x
Profitable years 6
Rev. volatility 0.96%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o SNN
Online

O podjetju

Smith & Nephew plc (SN) is a British company specializing in the manufacture and distribution of healthcare devices and surgical products. Their portfolio includes a wide range of products in the fields of orthopedics, sports medicine, joint surgery, traumatology, and advanced surgical technologies. The company manufactures and supplies implants, prosthetics, instruments, and devices for orthopedic surgeries, as well as products for wound care, skin care, and other surgical needs. Smith & Nephew focuses on providing innovative and high-quality products that help physicians achieve better outcomes for their patients. The company also invests in research and development of new technologies and products to continuously innovate and improve its portfolio. Smith & Nephew plc (SN) shares may be attractive to investors seeking investments in companies operating in the healthcare devices sector with a wide range of products and an emphasis on innovation and quality.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Deepak S. Nath

Employees

18,362

Headquarters

Watford

Prihajajoči dogodki

23 FEB.

Earnings

Upcoming earnings report

142d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.